CSS LLC’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-25,500
| Closed | -$1.18M | – | 892 |
|
|
2019
Q2 | $1.18M | Sell |
25,500
-16,300
| -39% | -$458K | 0.07% | 192 |
|
|
2019
Q1 | $1.02M | Sell |
41,800
-109,000
| -72% | -$2.27M | 0.06% | 203 |
|
|
2018
Q4 | $2.15M | Buy |
150,800
+10,000
| +7% | +$152K | 0.14% | 130 |
|
|
2018
Q3 | $2.14M | Buy |
140,800
+30,000
| +27% | +$460K | 0.09% | 131 |
|
|
2018
Q2 | $1.86M | Buy |
110,800
+2,000
| +2% | +$31.8K | 0.09% | 154 |
|
|
2018
Q1 | $1.77M | Buy |
108,800
+16,200
| +17% | +$260K | 0.09% | 157 |
|
|
2017
Q4 | $1.19M | Sell |
92,600
-144,700
| -61% | -$1.65M | 0.06% | 209 |
|
|
2017
Q3 | $2.92M | Sell |
237,300
-157,100
| -40% | -$1.46M | 0.14% | 123 |
|
|
2017
Q2 | $3.3M | Buy |
394,400
+272,600
| +224% | +$2.23M | 0.16% | 118 |
|
|
2017
Q1 | $1.09M | Buy |
121,800
+111,800
| +1,118% | +$1.19M | 0.07% | 202 |
|
|
2016
Q4 | $88K | Sell |
10,000
-50,200
| -83% | -$369K | ﹤0.01% | 618 |
|
|
2016
Q3 | $407K | Buy |
60,200
+40,200
| +201% | +$155K | 0.02% | 416 |
|
|
2016
Q2 | $72K | Hold |
20,000
| – | – | ﹤0.01% | 645 |
|
|
2016
Q1 | $59K | Sell |
20,000
-170,000
| -89% | -$509K | ﹤0.01% | 617 |
|
|
2015
Q4 | $802K | Buy |
190,000
+132,500
| +230% | +$605K | 0.05% | 273 |
|
|
2015
Q3 | $262K | Buy |
57,500
+47,500
| +475% | +$282K | 0.02% | 524 |
|
|
2015
Q2 | $72K | Sell |
10,000
-50,000
| -83% | -$369K | ﹤0.01% | 720 |
|
|
2015
Q1 | $442K | Sell |
60,000
-30,000
| -33% | -$214K | 0.02% | 457 |
|
|
2014
Q4 | $426K | Buy |
+90,000
| New | +$356K | 0.02% | 477 |
|
Other funds holding ARRY
CSS LLC's ARRY Position: Q3 2019 in Review
CSS LLC sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 900 shares — an estimated $42K sold.
CSS LLC first reported a position in ARRY in Q4 2017 and held it in 2 quarters. The position peaked at $65K in Q4 2017. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- CSS LLC reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- CSS LLC sold 900 Array Biopharma Inc shares in Q3 2019, an estimated $42K.
- CSS LLC first reported a position in Array Biopharma Inc in Q4 2017 and held it in 2 quarters.
- CSS LLC's Array Biopharma Inc position peaked at $65K in Q4 2017.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on CSS LLC's 13F filing for Q3 2019, filed 14 Nov 2019.